Ghost Tree Capital, LLC Celldex Therapeutics, Inc. Transaction History

Ghost Tree Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$27.64 - $39.32 $1.38 Million - $1.97 Million	-50,000 Reduced 14.29%	300,000 $10.2 Million
Q4 2021 Feb 16, 2022	BUY	$35.68 - $56.27 $3.39 Million - $5.35 Million	95,000 Added 37.25%	350,000 $13.5 Million
Q3 2021 Nov 15, 2021	SELL	$28.95 - $55.99 $868,500 - $1.68 Million	-30,000 Reduced 10.53%	255,000 $13.8 Million
Q2 2021 Aug 11, 2021	BUY	$20.71 - $35.37 $724,850 - $1.24 Million	35,000 Added 14.0%	285,000 $9.53 Million
Q1 2021 May 14, 2021	BUY	$16.19 - $29.91 $4.05 Million - $7.48 Million	250,000 New	250,000 $5.15 Million

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.26B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.